BioMaxima Income Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	59.11	52.85	46.79	143.87	79.09	61.28
Revenue Growth (YoY)	17.50%	12.96%	-67.48%	81.91%	29.06%	100.19%
Cost of Revenue	31.16	27.79	25.11	87.86	48.94	37.74
Gross Profit	27.95	25.06	21.68	56.01	30.15	23.55
Selling, General & Admin	22.15	19.46	18.22	17.49	15.29	11.85
Other Operating Expenses	0.86	0.96	0.95	1.67	-0.39	0.47
Operating Expenses	26.62	23.78	21.48	21.11	16.49	14.17
Operating Income	1.34	1.29	0.2	34.9	13.65	9.38
Interest Expense	-1.12	-0.98	-0.61	-0.48	-0.2	-0.34
Interest & Investment Income	0.16	0	0.14	0.8	-	0.1
Currency Exchange Gain (Loss)	-0.12	-0.12	-0.2	-0.01	-0.06	-0.2
Other Non Operating Income (Expenses)	0.15	0.1	0.77	0.69	-0.67	-0.03
EBT Excluding Unusual Items	0.42	0.3	0.3	35.9	12.72	8.91
Gain (Loss) on Sale of Assets	0.09	0.02	0.02	0	0.06	0.11
Asset Writedown	-0.01	-0.01	-0.13	-0.03	-	0.55
Pretax Income	0.5	0.31	0.19	35.87	12.78	9.57
Income Tax Expense	-0.15	-0.23	-0.4	6.98	2.53	1.62
Earnings From Continuing Operations	0.65	0.54	0.59	28.89	10.24	7.95
Net Income	0.65	0.54	0.59	28.89	10.24	7.95
Net Income to Common	0.65	0.54	0.59	28.89	10.24	7.95
Net Income Growth	-	-8.70%	-97.97%	182.00%	28.86%	-
Shares Outstanding (Basic)	4	4	4	4	4	4
Shares Outstanding (Diluted)	4	4	4	4	4	4
Shares Change (YoY)	0.01%	-2.89%	-3.16%	-0.52%	4.45%	15.05%
EPS (Basic)	0.15	0.13	0.14	6.68	2.37	1.93
EPS (Diluted)	0.15	0.13	0.14	6.48	2.29	1.85
EPS Growth	-	-5.99%	-97.91%	182.97%	23.78%	-
Free Cash Flow	0.23	-2.42	-16.49	27.19	-4.61	2.09
Free Cash Flow Per Share	0.06	-0.58	-3.82	6.10	-1.03	0.49
Dividend Per Share	-	-	-	0.500	0.450	0.250
Dividend Growth	-	-	-	11.11%	80.00%	-
Gross Margin	47.29%	47.42%	46.34%	38.93%	38.12%	38.42%
Operating Margin	2.27%	2.43%	0.43%	24.26%	17.26%	15.30%
Profit Margin	1.10%	1.01%	1.25%	20.08%	12.95%	12.97%
Free Cash Flow Margin	0.39%	-4.58%	-35.24%	18.90%	-5.83%	3.41%
EBITDA	4.63	4.3	2.47	36.64	15.1	10.94
EBITDA Margin	7.84%	8.14%	5.29%	25.47%	19.09%	17.85%
D&A For EBITDA	3.29	3.02	2.27	1.74	1.45	1.56
EBIT	1.34	1.29	0.2	34.9	13.65	9.38
EBIT Margin	2.27%	2.43%	0.43%	24.26%	17.26%	15.30%
Effective Tax Rate	-	-	-	19.47%	19.82%	16.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.